Navigation Links
Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
Date:2/6/2009

an or objectives; the ability of the company to attract and retain qualified personnel; competition in general; and the company's ability to obtain, maintain and enforce patent and other intellectual property protection for its product candidates and its discoveries. These and other risks which may impact management's expectations are described in greater detail under the caption "Risk Factors" in the company's annual report on Form 10-K for the year ended December 31, 2007 and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, each as filed with the Securities and Exchange Commission (SEC) and other filings that the company makes with the SEC.

All forward-looking statements reflect the company's expectations only as of the date of this release and should not be relied upon as reflecting the company's views, expectations or beliefs at any date subsequent to the date of this release. Idenix anticipates that subsequent events and developments may cause these views, expectations and beliefs to change. However, while Idenix may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.

    Idenix Pharmaceuticals Contacts:
    Amy Sullivan 617-995-9838 (investors)
    Teri Dahlman 617-995-9905 (media)

    GlaxoSmithKline Contacts:

    UK Media enquiries:                  Philip Thomson  (020) 8047 5502
                                         Alice Hunt      (020) 8047 5502
                                         David Outhwaite (020) 8047 5502
                                         Stephen Rea     (020) 8047 5502

    US Media enquiries:                  Nancy Pekarek    (919) 483 2839
                                         Mary Anne Rhyne  (919) 483 2839
                                         Kevin Colgan     (919) 483 2839
                                         Sarah Alspach    (215) 751 7709

    European Ana
'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
2. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
3. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
4. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
5. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
7. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
8. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
9. Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
10. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
11. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Serco Inc., a ... the Company has been awarded a re-compete contract ... (NEMSCOM) and its Deployable Medical Systems.  Serco will ... personnel to provide world-class healthcare to meet warfighter ... across the globe. The five year contract has ...
(Date:7/28/2014)... , July 28, 2014  Air Products (NYSE: ... supply of medical oxygen is vital to any healthcare ... innovations that not only improve the efficiency of its ... Products will highlight these systems—including systems for emergency ... oxygen loss—from August 4-5 at the 51 st ...
(Date:7/28/2014)... , July 28, 2014  VigeneTech, Inc, in ... of LEGENDplex™ Data Analysis Software, an OEM software ... cytometers.  BioLegend develops and offers varieties of bead-based ... With the support of VigeneTech,s data analysis software, ... analyzed and easily reported LEGENDplex™ ...
Breaking Medicine Technology:Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... Nov. 15, 2011 On November 14, 2011, DHS ... will enter into preliminary talks with Radient Pharmaceuticals Corporation ... both parties.  However, that press release was issued without ... any further discussions, or enter into any business opportunities ...
... ICU Medical, Inc. (NASDAQ: ICUI ) today ... Novation for its full line of Critical Care products, ... in-line blood sampling systems. Effective January 1, 2012, the ... take advantage of special pricing and terms pre-negotiated by ...
Cached Medicine Technology:Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation 2Novation Awards ICU Medical, Inc. a New Contract to Supply Members With a Complete Line of Clinically-Preferred Critical Care Products 2
(Date:7/28/2014)... (PRWEB) July 28, 2014 With California ... it is welcome news that a fire blanket ... current protection is under development by SunSeeker Enterprises, Inc. ... to protect spacecraft from the extreme heat of re-entry ... both firefighters and homes. , “Our firefighters routinely lay ...
(Date:7/28/2014)... At some point in their lives, almost everyone will be ... authorities. Distinguishing the circumstances where this is proper is ... every dangerous situation is going to be as blatant as ... a bank get held up. Many dangerous predicaments are ... than they otherwise should. , The Law Offices of Christopher ...
(Date:7/28/2014)... Windsor, Co (PRWEB) July 28, 2014 ... Colorado has unveiled new plans to raise investment capital ... growing 24/7 fitness concept in the United States. , ... increasing popularity of 24/7 fitness centers provide a great ... into this rapidly expanding space. In addition to this, ...
(Date:7/28/2014)... 28, 2014 The report “Industrial ... (Food & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed), ... 2018” defines and segments the global industrial enzymes ... value for industrial enzymes. It also identifies driving ... market with analysis of trends, opportunities, burning issues, ...
(Date:7/28/2014)... Medicine (BUSM) report variants in a new gene, PLXNA4, ... (AD). The discovery of this novel genetic association may ... specifically. These findings appear in the Annals of ... dementia affecting 5.4 million Americans including 13 percent of ... percent of people age 85 and older. Genetic factors ...
Breaking Medicine News(10 mins):Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Take Action To Protect Your Fellow Citizens 2Health News:Take Action To Protect Your Fellow Citizens 3Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4Health News:Researchers identify potential biomarker for AD 2
... provider offers real estate community ... harmful vapor intrusion, MILFORD, Conn., April 28 ... provider of environmental risk information,services and solutions, today ... level of awareness of the health, investment and ...
... Company,s Military Logistics and Health Care ... Service ... LMT ) has entered into a definitive agreement to acquire,Atlanta, Georgia ... and healthcare services to the,U.S. Department of Defense., As part ...
... raising complication risks, study finds, , , MONDAY, April 28 (HealthDay ... type 1 or type 2 diabetes has doubled since 1999, ... research finds. , In some age groups, the results were ... of teenagers who had diabetes before birth jumped fivefold. ...
... attend day care or play groups have about a ... of childhood leukaemia than those who do not, according ... , The new research, to be presented Tuesday ... of Childhood Leukaemia Conference in London, is the first ...
... President and Chief,Analyst Terence Pitre, Ph.D. Pitre Equity ... based in Minneapolis, Minnesota. Dr. Pitre,said that because ... academia, truth,independence and objectivity will always form the ... is to incorporate,fundamentally sound financial analysis that also ...
... leading provider of,Business Process Outsourcing solutions for ... and exhibiting at two upcoming healthcare,conferences. As ... mid-sized,health plans nationwide, Adaptis actively supports organizations ... with high-impact strategies for,improving member services while ...
Cached Medicine News:Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 2Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 3Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 2Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 3Health News:Pre-Pregnancy Diabetes Rates Have Doubled 2Health News:Pre-Pregnancy Diabetes Rates Have Doubled 3Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 2Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 3Health News:New Independent Research Firm Targets Firms with Little or No Analyst Following 2Health News:Adaptis Sponsors Two Upcoming Healthcare Conferences 2
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
... The new Finnpipette Focus from Thermo ... with uncompromising performance. Advanced features such ... .01ul fine volume adjustment on microvolumes help ... in single channel pipettes. The new interchangeable ...
... an immunochromatography based one step in vitro ... Opiates and its metabolite in human urine,specimens. ... above a cut-off level of 300 ng/mL,can ... evaluated in the point of care location ...
... test is an immunochromatography based one ... for qualitative determination of Methamphetamine in ... of 1000 ng/mL. This assay has ... of care,location and is for use ...
Medicine Products: